Cargando…

Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods

Three different Flow Cytometry datasets consisting of diagnostic samples of either peripheral blood (pB) or bone marrow (BM) from patients without any sign of bone marrow disease at two different health care centers are provided. In Flow Cytometry, each cell rapidly passes through a laser beam one b...

Descripción completa

Detalles Bibliográficos
Autores principales: Thrun, Michael C., Hoffmann, Jörg, Röhnert, Maximilian, von Bonin, Malte, Oelschlägel, Uta, Brendel, Cornelia, Ultsch, Alfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253476/
https://www.ncbi.nlm.nih.gov/pubmed/35799850
http://dx.doi.org/10.1016/j.dib.2022.108382
_version_ 1784740495124070400
author Thrun, Michael C.
Hoffmann, Jörg
Röhnert, Maximilian
von Bonin, Malte
Oelschlägel, Uta
Brendel, Cornelia
Ultsch, Alfred
author_facet Thrun, Michael C.
Hoffmann, Jörg
Röhnert, Maximilian
von Bonin, Malte
Oelschlägel, Uta
Brendel, Cornelia
Ultsch, Alfred
author_sort Thrun, Michael C.
collection PubMed
description Three different Flow Cytometry datasets consisting of diagnostic samples of either peripheral blood (pB) or bone marrow (BM) from patients without any sign of bone marrow disease at two different health care centers are provided. In Flow Cytometry, each cell rapidly passes through a laser beam one by one, and two light scatter, and eight surface parameters of more than 100.000 cells are measured per sample of each patient. The technology swiftly characterizes cells of the immune system at the single-cell level based on antigens presented on the cell surface that are targeted by a set of fluorochrome-conjugated antibodies. The first dataset consists of N=14 sample files measured in Marburg and the second dataset of N=44 data files measured in Dresden, of which half are BM samples and half are pB samples. The third dataset contains N=25 healthy bone marrow samples and N=25 leukemia bone marrow samples measured in Marburg. The data has been scaled to log between zero and six and used to identify cell populations that are simultaneously meaningful to the clinician and relevant to the distinction of pB vs BM, and BM vs leukemia. Explainable artificial intelligence methods should distinguish these samples and provide meaningful explanations for the classification without taking more than several hours to compute their results. The data described in this article are available in Mendeley Data [1].
format Online
Article
Text
id pubmed-9253476
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92534762022-07-06 Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods Thrun, Michael C. Hoffmann, Jörg Röhnert, Maximilian von Bonin, Malte Oelschlägel, Uta Brendel, Cornelia Ultsch, Alfred Data Brief Data Article Three different Flow Cytometry datasets consisting of diagnostic samples of either peripheral blood (pB) or bone marrow (BM) from patients without any sign of bone marrow disease at two different health care centers are provided. In Flow Cytometry, each cell rapidly passes through a laser beam one by one, and two light scatter, and eight surface parameters of more than 100.000 cells are measured per sample of each patient. The technology swiftly characterizes cells of the immune system at the single-cell level based on antigens presented on the cell surface that are targeted by a set of fluorochrome-conjugated antibodies. The first dataset consists of N=14 sample files measured in Marburg and the second dataset of N=44 data files measured in Dresden, of which half are BM samples and half are pB samples. The third dataset contains N=25 healthy bone marrow samples and N=25 leukemia bone marrow samples measured in Marburg. The data has been scaled to log between zero and six and used to identify cell populations that are simultaneously meaningful to the clinician and relevant to the distinction of pB vs BM, and BM vs leukemia. Explainable artificial intelligence methods should distinguish these samples and provide meaningful explanations for the classification without taking more than several hours to compute their results. The data described in this article are available in Mendeley Data [1]. Elsevier 2022-06-17 /pmc/articles/PMC9253476/ /pubmed/35799850 http://dx.doi.org/10.1016/j.dib.2022.108382 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Data Article
Thrun, Michael C.
Hoffmann, Jörg
Röhnert, Maximilian
von Bonin, Malte
Oelschlägel, Uta
Brendel, Cornelia
Ultsch, Alfred
Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods
title Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods
title_full Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods
title_fullStr Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods
title_full_unstemmed Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods
title_short Flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods
title_sort flow cytometry datasets consisting of peripheral blood and bone marrow samples for the evaluation of explainable artificial intelligence methods
topic Data Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253476/
https://www.ncbi.nlm.nih.gov/pubmed/35799850
http://dx.doi.org/10.1016/j.dib.2022.108382
work_keys_str_mv AT thrunmichaelc flowcytometrydatasetsconsistingofperipheralbloodandbonemarrowsamplesfortheevaluationofexplainableartificialintelligencemethods
AT hoffmannjorg flowcytometrydatasetsconsistingofperipheralbloodandbonemarrowsamplesfortheevaluationofexplainableartificialintelligencemethods
AT rohnertmaximilian flowcytometrydatasetsconsistingofperipheralbloodandbonemarrowsamplesfortheevaluationofexplainableartificialintelligencemethods
AT vonboninmalte flowcytometrydatasetsconsistingofperipheralbloodandbonemarrowsamplesfortheevaluationofexplainableartificialintelligencemethods
AT oelschlageluta flowcytometrydatasetsconsistingofperipheralbloodandbonemarrowsamplesfortheevaluationofexplainableartificialintelligencemethods
AT brendelcornelia flowcytometrydatasetsconsistingofperipheralbloodandbonemarrowsamplesfortheevaluationofexplainableartificialintelligencemethods
AT ultschalfred flowcytometrydatasetsconsistingofperipheralbloodandbonemarrowsamplesfortheevaluationofexplainableartificialintelligencemethods